/organisation/aitia-gns-healthcare-group-somerville-massachusetts-federal-state-2001-48977.html

Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x100px
Organisation › Details

Aitia (GNS Healthcare) (Group)

Aitia is a leader in the application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs. By leveraging the convergence of multi-omic patient data, high-performance computing, and causal learning and AI, Aitia is revealing the hidden biological mechanisms of disease to create Digital Twins of disease in oncology, neurodegenerative disorders, and immunology. Gemini Digital Twins are being used today to discover novel therapies and accelerate R&D in multiple myeloma, prostate cancer, Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease, with several more in development. Aitia’s partners include seven of the top ten pharmaceutical companies, leading academic research and medical centers, medical societies, leading multi-omic data companies, and patient advocacy groups globally. *

 

Period Start 2023-01-09 renamed
Products Industry AI-based drug discovery / AI-based drug development
  Industry 2 digital twin (simulation software / virtual reality (VR))
Persons Person Hill, Colin (Aitia 202303 CEO + Co-Founder formerly Gene Network 200708 CEO)
  Person 2 Donahue, Joseph F. (Joe) (GNS Healthcare 202204– CBO before Accenture + GeneDx + Thomson Reuters + Inforsense)
     
  Street 561 Windsor Street
  City 02143 Somerville, MA
  Tel +1-617-374-2300
    Address record changed: 2024-01-05
     
Basic data Employees n. a.
     
    * Document for »About Section«: UCB S.A.. (3/15/23). "Press Release: Aitia and UCB Announce Strategic Drug Discovery Collaboration in Huntington's Disease". Brussels & Somerville, MA.
     
   
Record changed: 2023-07-10

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Aitia (GNS Healthcare) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x300px




» top